Cargando…

Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease

INTRODUCTION: Crohn's disease (CD) promotes the development of osteopaenia/osteoporosis, the cytokine background of which is not fully known. AIM: Evaluation of bone mineral density (BMD), the prevalence of osteopaenia and osteoporosis, and the determination of the levels of selected interleuki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krela-Kaźmierczak, Iwona, Wysocka, Ewa, Szymczak, Aleksandra, Eder, Piotr, Michalak, Michał, Łykowska-Szuber, Liliana, Stawczyk-Eder, Kamila, Klimczak, Katarzyna, Linke, Krzysztof, Horst-Sikorska, Wanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814538/ https://www.ncbi.nlm.nih.gov/pubmed/27110308 http://dx.doi.org/10.5114/pg.2015.52589

Ejemplares similares

The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
por: Eder, Piotr, et al.
Publicado: (2015)

The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity
por: Eder, Piotr, et al.
Publicado: (2015)

Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn’s disease
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2015)

Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study
por: Stawczyk-Eder, Kamila, et al.
Publicado: (2015)

Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn’s disease naive to anti-TNF agents
por: Eder, Piotr, et al.
Publicado: (2015)

Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2014)

Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease
por: Eder, Piotr, et al.
Publicado: (2015)

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2023)

Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
por: Krela-Kazmierczak, Iwona, et al.
Publicado: (2018)

Bone Metabolism and the c.-223C > T Polymorphism in the 5′UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2016)

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s Disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2019)

Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
por: Walczak, Michal, et al.
Publicado: (2020)

Diet and Nutritional Factors in Male (In)fertility—Underestimated Factors
por: Skoracka, Kinga, et al.
Publicado: (2020)

Dietary Support in Elderly Patients with Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)—A Narrative Review
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2021)

Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury
por: Lubarska, Marta, et al.
Publicado: (2023)

Current management of anal fistulas in Crohn's disease
por: Hermann, Jacek, et al.
Publicado: (2015)

What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2021)

Why Does Obesity as an Inflammatory Condition Predispose to Colorectal Cancer?
por: Rychter, Anna Maria, et al.
Publicado: (2023)

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease
por: Rychter, Anna Maria, et al.
Publicado: (2021)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Multidimensional Disadvantages of a Gluten-Free Diet in Celiac Disease: A Narrative Review
por: Marciniak, Martyna, et al.
Publicado: (2021)

A Vicious Cycle of Osteosarcopenia in Inflammatory Bowel Diseases—Aetiology, Clinical Implications and Therapeutic Perspectives
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2022)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

Association of salivary RANKL and osteoprotegerin levels with periodontal health
por: Ochanji, A. A., et al.
Publicado: (2017)

Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
por: Irtyuga, Olga, et al.
Publicado: (2017)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023)

The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
por: Starlinger, Julia, et al.
Publicado: (2019)

Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults
por: Malesza, Ida Judyta, et al.
Publicado: (2020)

Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
por: Kohli, Sarvraj Singh, et al.
Publicado: (2011)

Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis
por: Behfarnia, Parichehr, et al.
Publicado: (2016)

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes
por: Kondegowda, Nagesha Guthalu, et al.
Publicado: (2023)

Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL
por: Schieferdecker, Aneta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1v26t4pdb6cl4iren0j2pbu8mf